Liliana Vartolomei, Sabin Octavian Tătaru, Andrei Cotruș, Camelia Stanciu & Anca Ileana Sin. (2023) Testosterone deficiency is associated with clinically relevant depression symptoms. Acta Marisiensis - Seria Medica 69:1, pages 50-54.
Crossref
Elaine Maria Frade Costa, Lorena Guimarães Lima Amato & Leticia Ferreira Gontijo Silveira. 2023. Testosterone. Testosterone
331
347
.
Tristan MarhenkeTristan Marhenke. 2022. Sexual Disorders. Sexual Disorders
3
27
.
Paolo Verze, Raffaele Baio, Luigi Napolitano & Vincenzo Mirone. 2022. Men’s Health and Wellbeing. Men’s Health and Wellbeing
31
43
.
C. Burte, H. Lejeune, A. Faix, P. Desvaux, T. Almont, B. Cuzin & E. Huyghe. (2021) Recommandations pratiques pour la prise en charge du déficit en testostérone. Progrès en Urologie 31:8-9, pages 458-476.
Crossref
Francesco Del Giudice, Frank Glover, Federico Belladelli, Ettore De Berardinis, Alessandro Sciarra, Stefano Salciccia, Alex M. Kasman, Tony Chen & Michael L. Eisenberg. (2021) Association of daily step count and serum testosterone among men in the United States. Endocrine 72:3, pages 874-881.
Crossref
Hye-Min Park, Haeyoung Kim, Hye Sun Lee & Yong-Jae Lee. (2021) Inverse association between serum bilirubin level and testosterone deficiency in middle-aged and older men. Scientific Reports 11:1.
Crossref
Vito Angelo Giagulli, Marco Castellana, Giuseppe Lisco & Vincenzo Triggiani. (2020) Critical evaluation of different available guidelines for late‐onset hypogonadism. Andrology 8:6, pages 1628-1641.
Crossref
E. Nieschlag. (2019) Late‐onset hypogonadism: a concept comes of age. Andrology 8:6, pages 1506-1511.
Crossref
Jialiang Hui, Shuhua He, Ruiyu Liu, Qinyu Zeng, Haibo Zhang & Anyang Wei. (2019) Trends in erectile dysfunction research from 2008 to 2018: a bibliometric analysis. International Journal of Impotence Research 32:4, pages 409-419.
Crossref
Antoine Lemaire. (2020) Comment je traite… une dysfonction érectile. La Presse Médicale Formation 1:2, pages 203-206.
Crossref
L. Ferretti & A. Gagnat. (2020) Déficit androgénico ligado a la edad. EMC - Urología 52:2, pages 1-5.
Crossref
Brittni M. Usera, Polly Creveling & Jonathan D. Tward. (2020) Impact and Outcomes of Pretreatment Total Serum Testosterone on Localized Prostate Cancer Patients. Prostate Cancer 2020, pages 1-9.
Crossref
Sherilyn Tan, Hamid R. Sohrabi, Michael Weinborn, Michelle Tegg, Romola S. Bucks, Kevin Taddei, Malcolm Carruthers & Ralph N. Martins. (2019) Effects of Testosterone Supplementation on Separate Cognitive Domains in Cognitively Healthy Older Men: A Meta-analysis of Current Randomized Clinical Trials. The American Journal of Geriatric Psychiatry 27:11, pages 1232-1246.
Crossref
SangJoon Mo. (2019)
Effect of increasing nitric oxide and dihydrotestosterone by
Taraxacum coreanum
extract
. Journal of Applied Biological Chemistry 62:3, pages 305-313.
Crossref
Judith Gebauer, Claire Higham, Thorsten Langer, Christian Denzer & Georg Brabant. (2019) Long-Term Endocrine and Metabolic Consequences of Cancer Treatment: A Systematic Review. Endocrine Reviews 40:3, pages 711-767.
Crossref
Andrzej PÓŁTORAK, Monika MARCINKOWSKA-LESIAK, Krzysztof LENDZION, Anna ONOPIUK, Małgorzata MOCZKOWSKA, Iwona WOJTASIK-KALINOWSKA & Agnieszka WIERZBICKA. (2019) The effect of bioactive components of plant origin on the physicochemical and sensory characteristics of functional sausages. Food Science and Technology 39:1, pages 232-239.
Crossref
Supanut Lumbiganon, Suthep Patcharatrakul, Wisoot Khongcharoensombat & Premsant Sangkum. (2019) Pre- and post-radical prostatectomy testosterone levels in prostate cancer patients. International Journal of Impotence Research 31:2, pages 145-149.
Crossref
E. A. Kondrasheva, N. A. Igonina, E. M. Khasyanova, A. A. Salikhova, E. A. Zhuravleva, S. N. Sysoeva, T. A. Makarova, I. G. Torshina & E. V. Chashchikhina. (2019) Testosterone: diagnostic threshold, method-specific 'expected values' from the manufacturer, reference values developed in a laboratory10. Laboratornaya sluzhba 8:2, pages 10.
Crossref
Kazuyoshi Shigehara, Hiroyuki Konaka, Yuki Kato, Masashi Iijima, Kazufumi Nakashima, Shohei Kawaguchi, Takahiro Nohara, Kouji Izumi, Mikio Namiki & Atsushi Mizokami. (2018) Effect of testosterone replacement therapy on sexual function and glycemic control among hypogonadal men with type 2 diabetes mellitus. International Journal of Impotence Research 31:1, pages 25-30.
Crossref
Michele D. Mignogna & Stefania Leuci. 2019. Contemporary Oral Medicine. Contemporary Oral Medicine
67
136
.
Giacomo Montagna, Samuela Balestra, Federica D’Aurizio, Francesco Romanelli, Cinzia Benagli, Renato Tozzoli, Lorenz Risch, Luca Giovanella & Mauro Imperiali. (2018) Establishing normal values of total testosterone in adult healthy men by the use of four immunometric methods and liquid chromatography-mass spectrometry. Clinical Chemistry and Laboratory Medicine (CCLM) 56:11, pages 1936-1944.
Crossref
M. Algeffari, C. N. Jayasena, P. MacKeith, A. Thapar, W. S. Dhillo & N. Oliver. (2018) Testosterone therapy for sexual dysfunction in men with Type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabetic Medicine 35:2, pages 195-202.
Crossref
Sidika E. Karakas & Prasanth Surampudi. 2018.
71
125
.
Hans-Christian Schuppe & Frank-Michael Köhn. 2018. Braun-Falco's Dermatologie, Venerologie und Allergologie. Braun-Falco's Dermatologie, Venerologie und Allergologie
1
36
.
Hans-Christian Schuppe & Frank-Michael Köhn. 2018. Braun-Falco’s Dermatologie, Venerologie und Allergologie. Braun-Falco’s Dermatologie, Venerologie und Allergologie
1547
1582
.
Michele D. Mignogna & Stefania Leuci. 2018. Contemporary Oral Medicine. Contemporary Oral Medicine
1
70
.
Hiroki Maita, Tadashi Kobayashi, Hiroshi Hiroshi Osawa, Takahiro Hirano & Hiroyuki Kato. (2017) Symptoms of hypogonadism caused by 5α-reductase inhibitors. International Journal of Family & Community Medicine 1:3.
Crossref
Mark Livingston, Anura Kalansooriya, Andrew J. Hartland, Sudarshan Ramachandran & Adrian Heald. (2017) Serum testosterone levels in male hypogonadism: Why and when to check-A review. International Journal of Clinical Practice 71:11, pages e12995.
Crossref
Hans-Christian Schuppe, Thorsten Diemer & Frank-Michael Köhn. (2017) Testosteronsubstitution – wann und wie?. Journal für Klinische Endokrinologie und Stoffwechsel 10:3, pages 60-66.
Crossref
Paweł J. Wiechno, Maria Kowalska, Jakub Kucharz, Małgorzata Sadowska, Wojciech Michalski, Grażyna Poniatowska, Joanna Jońska-Gmyrek, Joanna Rzymkowska, Karol Nietupski & Tomasz Demkow. (2017) Dynamics of hormonal disorders following unilateral orchiectomy for a testicular tumor. Medical Oncology 34:5.
Crossref
Hans-Christian Schuppe, Thorsten Diemer & Frank-Michael Köhn. (2017) Testosteronsubstitution — wann und wie?. Uro-News 21:4, pages 52-60.
Crossref
Jonas Čeponis, Ronald S. Swerdloff & Christina Wang. 2017. Male Hypogonadism. Male Hypogonadism
367
397
.
Elaine Maria Frade Costa, Lorena Guimarães Lima Amato & Leticia Ferreira Gontijo Silveira. 2017. Testosterone. Testosterone
253
269
.
Jason C. Chandrapal, Spencer Nielson, Darshan P. Patel, Chong Zhang, Angela P. Presson, William O. Brant, Jeremy B. Myers & James M. Hotaling. (2016) Characterising the safety of clomiphene citrate in male patients through prostate-specific antigen, haematocrit, and testosterone levels. BJU International 118:6, pages 994-1000.
Crossref
Aniruddha Das & Nicole Sawin. (2016) Social Modulation or Hormonal Causation? Linkages of Testosterone with Sexual Activity and Relationship Quality in a Nationally Representative Longitudinal Sample of Older Adults. Archives of Sexual Behavior 45:8, pages 2101-2115.
Crossref
Xubo Shen, Ruifeng Wang, Na Yu, Yongjun Shi, Honggang Li, Chengliang Xiong, Yan Li, Ellen M. Wells & Yuanzhong Zhou. (2016) Reference Ranges and Association of Age and Lifestyle Characteristics with Testosterone, Sex Hormone Binding Globulin, and Luteinizing Hormone among 1166 Western Chinese Men. PLOS ONE 11:10, pages e0164116.
Crossref
Mohit Khera. (2016) Testosterone Therapies. Urologic Clinics of North America 43:2, pages 185-193.
Crossref
Fouad Aoun, Anthony Kallas Chemaly, Simone Albisinni, Marc Zanaty & Thierry Roumeguere. (2016) In Search for a Common Pathway for Health Issues in Men - the Sign of a Holmesian Deduction. Asian Pacific Journal of Cancer Prevention 17:1, pages 1-13.
Crossref
K. L. Melehan, C. M. Hoyos, B. J. Yee, K. K. Wong, P. R. Buchanan, R. R. Grunstein & P. Y. Liu. (2016) Increased sexual desire with exogenous testosterone administration in men with obstructive sleep apnea: a randomized placebo-controlled study. Andrology 4:1, pages 55-61.
Crossref
Joel J. Heidelbaugh, Anthony Grech & Martin M. Miner. 2016. Men's Health in Primary Care. Men's Health in Primary Care
249
267
.
Neil Goodman, Andre Guay, Paresh Dandona, Sandeep Dhindsa, Charles Faiman & Glenn R. Cunningham. (2015) American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on the Association of Testosterone and Cardiovascular Risk. Endocrine Practice 21:9, pages 1066-1073.
Crossref
Avni Mody, Donna White, Fasiha Kanwal & Jose M. Garcia. (2015) Relevance of low testosterone to nonalcoholic fatty liver disease. Cardiovascular Endocrinology 4:3, pages 83-89.
Crossref
Kyeong Soo Lee, Eun Kyung Lee, Shin Yeon Kim, Tae Hwan Kim & Hyun Pyo Kim. (2015) Effect of a Mixed Extract of Fenugreek Seeds and Lespedeza cuneata on Testosterone Deficiency Syndrome. Korean Journal of Food Science and Technology 47:4, pages 492-498.
Crossref
Rena D. Malik, Chihsiung E. Wang, Brittany Lapin, Justin C. Lakeman & Brian T. Helfand. (2015) Characteristics of Men Undergoing Testosterone Replacement Therapy and Adherence to Follow-up Recommendations in Metropolitan Multicenter Health Care System. Urology 85:6, pages 1382-1388.
Crossref
Роман Викторович Роживанов & Юлия Николаевна Яшина. (2015) Aspects of androgen replacement therapy for the treatment of hypogonadism in men with diabetes and metabolic syndrome.. Obesity and metabolism 12:1, pages 11-14.
Crossref
Martin Stout, Keith Pearce & Simon G. Williams. (2015) A novel application of salivary testosterone in systolic heart failure. Cardiovascular Endocrinology 4:1, pages 28-38.
Crossref
Farid SaadAksam YassinAhmad HaiderGheorghe DorosLouis Gooren. (2015) Elderly men over 65 years of age with late-onset hypogonadism benefit as much from testosterone treatment as do younger men. Korean Journal of Urology 56:4, pages 310.
Crossref
Leena Nahata, Richard N. Yu, Shalender Bhasin & Laurie E. Cohen. (2015) Management of testosterone therapy in adolescents and young men with hypogonadism: are we following adult clinical practice guidelines?. Journal of Pediatric Endocrinology and Metabolism 28:5-6.
Crossref
Rena D. Malik, Brittany Lapin, Chihsiung E. Wang, Justin C. Lakeman & Brian T. Helfand. (2015) Are We Testing Appropriately for Low Testosterone?: Characterization of Tested Men and Compliance with Current Guidelines. The Journal of Sexual Medicine 12:1, pages 66-75.
Crossref
Molly M. Shores. (2014) The Implications of Low Testosterone on Mortality in Men. Current Sexual Health Reports 6:4, pages 235-243.
Crossref
AM Martits, EMF Costa, AC Nardi, A Nardozza Jr.FN Facio Jr.G Faria & WM Bernardo. (2014) Late-onset hypogonadism or ADAM: treatment. Revista da Associação Médica Brasileira 60:5, pages 404-414.
Crossref
Antoine Lemaire. (2014) Endocrinopathies, maladies métaboliques et sexualité. La Presse Médicale 43:10, pages 1089-1096.
Crossref
A. George & R. Henkel. (2014)
Phytoandrogenic properties of
Eurycoma longifolia
as natural alternative to testosterone replacement therapy
. Andrologia 46:7, pages 708-721.
Crossref
Håkan Olsson, Rikard Sandström, Anders Neijber, Dario Carrara & Lars Grundemar. (2014) Pharmacokinetics and bioavailability of a new testosterone gel formulation in comparison to Testogel® in healthy men. Clinical Pharmacology in Drug Development 3:5, pages 358-364.
Crossref
AM Martits, EMF Costa, AC Nardi, A Nardozza Jr, G Faria, FN Facio Jr & WM Bernardo. (2014) Late-onset hypogonadism or ADAM: diagnosis. Revista da Associação Médica Brasileira 60:4, pages 286-294.
Crossref
Masaki Taya, Eitetsu Koh, Kouji Izumi, Masashi Iijima, Yuji Maeda, Tomohiko Matsushita, Teruaki Iwamoto & Mikio Namiki. (2014) Comparison of testosterone fractions between Framingham Heart Study participants and Japanese participants. International Journal of Urology 21:7, pages 689-695.
Crossref
J. Bradley Layton, Dongmei Li, Christoph R. Meier, Julie L. Sharpless, Til Stürmer, Susan S. Jick & M. Alan Brookhart. (2014) Testosterone Lab Testing and Initiation in the United Kingdom and the United States, 2000 to 2011. The Journal of Clinical Endocrinology & Metabolism 99:3, pages 835-842.
Crossref
Abdulmaged M. Traish, Andre T. Guay & Abraham Morgentaler. (2014) Death by Testosterone? We Think Not!. The Journal of Sexual Medicine 11:3, pages 624-629.
Crossref
Ahmad Mirdamadi, Mohammad Garakyaraghi, Ali Pourmoghaddas, Alireza Bahmani, Hamideh Mahmoudi & Mojgan Gharipour. (2014) Beneficial Effects of Testosterone Therapy on Functional Capacity, Cardiovascular Parameters, and Quality of Life in Patients with Congestive Heart Failure. BioMed Research International 2014, pages 1-7.
Crossref
Emmanuele A. Jannini, Andrea M. Isidori, Antonio Aversa, Andrea Lenzi & Stanley E. Althof. (2013) Which Is First? The Controversial Issue of Precedence in the Treatment of Male Sexual Dysfunctions. The Journal of Sexual Medicine 10:10, pages 2359-2369.
Crossref
Aniruddha Das & Stephanie Nairn. (2013) Race Differentials in Partnering Patterns among Older U.S. Men: Influence of Androgens or Religious Participation?. Archives of Sexual Behavior 42:7, pages 1119-1130.
Crossref
Ryan P. Smith, Abhinav Khanna, Robert M. Coward, Saneal Rajanahally, Jason R. Kovac, Marshall A. Gonzales & Larry I. Lipshultz. (2013) Factors Influencing Patient Decisions to Initiate and Discontinue Subcutaneous Testosterone Pellets (Testopel) for Treatment of Hypogonadism. The Journal of Sexual Medicine 10:9, pages 2326-2333.
Crossref
A. A. Yassin & G. Doros. (2013) Testosterone therapy in hypogonadal men results in sustained and clinically meaningful weight loss. Clinical Obesity 3:3-4, pages 73-83.
Crossref
John E. Morley. (2013) Hypogonadism, Testosterone, and Nursing Home Residents. Journal of the American Medical Directors Association 14:6, pages 381-383.
Crossref
John E. Morley. (2013) Scientific overview of hormone treatment used for rejuvenation. Fertility and Sterility 99:7, pages 1807-1813.
Crossref
Christian A. Koch & Michael Zitzmann. 2013. Endocrine Hypertension. Endocrine Hypertension
213
238
.
Wayland Hsiao & John P. Mulhall. 2013. Clinical Urologic Endocrinology. Clinical Urologic Endocrinology
41
57
.
Marcello Maggio, Fulvio Lauretani & Gian Paolo Ceda. (2012) Sex hormones and sarcopenia in older persons. Current Opinion in Clinical Nutrition and Metabolic Care, pages 1.
Crossref
E. J. Giltay, J. M. Geleijnse, A. C. Heijboer, J. de Goede, L. M. Oude Griep, M. A. Blankenstein & D. Kromhout. (2012) No effects of n−3 fatty acid supplementation on serum total testosterone levels in older men: the Alpha Omega Trial. International Journal of Andrology 35:5, pages 680-687.
Crossref
Pierre Olivier LangDimitrios SamarasNikolaos Samaras. (2012) Testosterone Replacement Therapy in Reversing “Andropause”: What Is the Proof-of-Principle?. Rejuvenation Research 15:5, pages 453-465.
Crossref
Eric Orwoll, Christence S. Teglbjærg, Bente L. Langdahl, Roland Chapurlat, Edward Czerwinski, David L. Kendler, Jean-Yves Reginster, Alan Kivitz, E. Michael Lewiecki, Paul D. Miller, Michael A. Bolognese, Michael R. McClung, Henry G. Bone, Östen Ljunggren, Bo Abrahamsen, Ugis Gruntmanis, Yu-Ching Yang, Rachel B. Wagman, Suresh Siddhanti, Andreas Grauer, Jesse W. Hall & Steven Boonen. (2012) A Randomized, Placebo-Controlled Study of the Effects of Denosumab for the Treatment of Men with Low Bone Mineral Density. The Journal of Clinical Endocrinology & Metabolism 97:9, pages 3161-3169.
Crossref
Hisham A. Mosli. (2012) Review Article: Practical Aspects of Testosterone Deficiency Syndrome in Clinical Urology. African Journal of Urology 18:3, pages 103-107.
Crossref
Katrina A. Abadilla & Adrian S. Dobs. (2012) Topical Testosterone Supplementation for the Treatment of Male Hypogonadism. Drugs 72:12, pages 1591-1603.
Crossref
Bernard Haendler & Arwed Cleve. (2012) Recent developments in antiandrogens and selective androgen receptor modulators. Molecular and Cellular Endocrinology 352:1-2, pages 79-91.
Crossref
Erik J. Giltay, Dorien Enter, Frans G. Zitman, Brenda W.J.H. Penninx, Johannes van Pelt, Phillip Spinhoven & Karin Roelofs. (2012) Salivary testosterone: Associations with depression, anxiety disorders, and antidepressant use in a large cohort study. Journal of Psychosomatic Research 72:3, pages 205-213.
Crossref
Andrew R. McCullough, Mohit Khera, Irwin Goldstein, Wayne J.G. Hellstrom, Abraham Morgentaler & Laurence A. Levine. (2012) A Multi‐Institutional Observational Study of Testosterone Levels after Testosterone Pellet (Testopel®) Insertion. The Journal of Sexual Medicine 9:2, pages 594-601.
Crossref
Jeremy B. Shelton & Jacob Rajfer. (2012) Androgen Deficiency in Aging and Metabolically Challenged Men. Urologic Clinics of North America 39:1, pages 63-75.
Crossref
Martin M. Miner. (2012) Men’s Health in Primary Care: An Emerging Paradigm of Sexual Function and Cardiometabolic Risk. Urologic Clinics of North America 39:1, pages 1-23.
Crossref
Anke Hannemann, Nele Friedrich, Christin Spielhagen, Matthias Nauck & Robin Haring. (2012) Sex-specific young adult reference ranges for sex hormone concentrations measured on the Siemens ADVIA Centaur/Geschlechtsspezifische Referenzbereiche für Sexualhormonkonzentrationen junger Erwachsener gemessen auf dem Siemens ADVIA Centaur. LaboratoriumsMedizin 36:1.
Crossref
Prasanth N. Surampudi, Christina Wang & Ronald Swerdloff. (2012) Hypogonadism in the Aging Male Diagnosis, Potential Benefits, and Risks of Testosterone Replacement Therapy. International Journal of Endocrinology 2012, pages 1-20.
Crossref
T. Scott Isbell, Emily Jungheim & Ann M. Gronowski. 2012. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics
1945
1990
.
Mohit Khera, Rajib K. Bhattacharya, Gary Blick, Harvey Kushner, Dat Nguyen & Martin M. Miner. (2011) Changes in Prostate Specific Antigen in Hypogonadal Men After 12 Months of Testosterone Replacement Therapy: Support for the Prostate Saturation Theory. Journal of Urology 186:3, pages 1005-1011.
Crossref
John E. Morley. (2011) Osteoporosis and Fragility Fractures. Journal of the American Medical Directors Association 12:6, pages 389-392.
Crossref
Abdulmaged M. Traish, Martin M. Miner, Abraham Morgentaler & Michael Zitzmann. (2011) Testosterone Deficiency. The American Journal of Medicine 124:7, pages 578-587.
Crossref
D S Frolov, Iu Sh Khalimov & S B Shustov. (2011) Age-related deficit of androgens in the male patients presenting with coronary heart disease. Problems of Endocrinology 57:2, pages 19-22.
Crossref
Hisanori Taniguchi, Gen Kawa, Hidefumi Kinoshita & Tadashi Matsuda. (2011) Change of aging males' symptoms (AMS) rating scale in Japanese late-onset hypogonadism (LOH) patients administered androgen replacement therapy. Journal of Men's Health 8:S1, pages S67-S70.
Crossref
Robin HaringSebastian E BaumeisterHenry VölzkeMarcus DörrStephan B FelixHeyo K KroemerMatthias NauckHenri Wallaschofski. (2010) Prospective association of low total testosterone concentrations with an adverse lipid profile and increased incident dyslipidemia. European Journal of Cardiovascular Prevention & Rehabilitation 18:1, pages 86-96.
Crossref
Kweon Sik MinDong Il Kang. (2011) Testosterone replacement therapy and monitoring for the male patients with testosterone deficiency syndrome. Journal of the Korean Medical Association 54:2, pages 197.
Crossref
Glenn R. Cunningham & Shivani M. Toma. (2011) Why Is Androgen Replacement in Males Controversial?. The Journal of Clinical Endocrinology & Metabolism 96:1, pages 38-52.
Crossref
Paul E Belchetz, Julian H Barth & Jean-Marc Kaufman. (2010) Biochemical endocrinology of the hypogonadal male. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 47:6, pages 503-515.
Crossref
Svetlana Y. Kalinchenko, Yuliya A. Tishova, George J. Mskhalaya, Louis J. G. Gooren, Erik J. Giltay & Farid Saad. (2010) Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double‐blinded placebo‐controlled Moscow study. Clinical Endocrinology 73:5, pages 602-612.
Crossref
Kevan Wylie, Margaret Rees, Geoff Hackett, Richard Anderson, Pierre-Marc Bouloux, Mike Cust, David Goldmeier, Philip Kell, Tim Terry, Tom Trinick & Frederick Wu. (2010) Androgens, health and sexuality in women and men. Maturitas 67:3, pages 275-289.
Crossref
Michael Zitzmann. (2010) Testosterone deficiency and treatment in older men: definition, treatment, pitfalls. Asian Journal of Andrology 12:5, pages 623-625.
Crossref
Erik J. Giltay, Yuliya A. Tishova, George J. Mskhalaya, Louis J.G. Gooren, Farid Saad & Svetlana Y. Kalinchenko. (2010) Effects of Testosterone Supplementation on Depressive Symptoms and Sexual Dysfunction in Hypogonadal Men with the Metabolic Syndrome. The Journal of Sexual Medicine 7:7, pages 2572-2582.
Crossref
Asif Muneer. (2010) Hypogonadism: an underdiagnosed condition. Trends in Urology, Gynaecology & Sexual Health 15:2, pages 14-17.
Crossref
John E. Morley. (2010) Hip Fractures. Journal of the American Medical Directors Association 11:2, pages 81-83.
Crossref
Nazem Bassil & John E. Morley. (2010) Endocrine Aspects of Healthy Brain Aging. Clinics in Geriatric Medicine 26:1, pages 57-74.
Crossref
John E Morley, Elie Chahla & Saad AlKaade. (2010) Antiaging, longevity and calorie restriction. Current Opinion in Clinical Nutrition and Metabolic Care 13:1, pages 40-45.
Crossref